97 related articles for article (PubMed ID: 17633454)
21. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin.
Xiao F; Wei Y; Yang L; Zhao X; Tian L; Ding Z; Yuan S; Lou Y; Liu F; Wen Y; Li J; Deng H; Kang B; Mao Y; Lei S; He Q; Su J; Lu Y; Niu T; Hou J; Huang MJ
Gene Ther; 2002 Sep; 9(18):1207-13. PubMed ID: 12215887
[TBL] [Abstract][Full Text] [Related]
22. Red- and green-emitting firefly luciferase mutants for bioluminescent reporter applications.
Branchini BR; Southworth TL; Khattak NF; Michelini E; Roda A
Anal Biochem; 2005 Oct; 345(1):140-8. PubMed ID: 16125663
[TBL] [Abstract][Full Text] [Related]
23. [Construction and activity of recombinant adeno-associated virus expressing vasostatin].
Diao Y; Ma J; Li X; Sun X; Xu R
Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1949-54. PubMed ID: 19256344
[TBL] [Abstract][Full Text] [Related]
24. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo.
Tannous BA; Kim DE; Fernandez JL; Weissleder R; Breakefield XO
Mol Ther; 2005 Mar; 11(3):435-43. PubMed ID: 15727940
[TBL] [Abstract][Full Text] [Related]
25. Sustained transgene expression in intervertebral disc cells in vivo mediated by microbubble-enhanced ultrasound gene therapy.
Nishida K; Doita M; Takada T; Kakutani K; Miyamoto H; Shimomura T; Maeno K; Kurosaka M
Spine (Phila Pa 1976); 2006 Jun; 31(13):1415-9. PubMed ID: 16741448
[TBL] [Abstract][Full Text] [Related]
26. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive monitoring of long-term lentiviral vector-mediated gene expression in rodent brain with bioluminescence imaging.
Deroose CM; Reumers V; Gijsbers R; Bormans G; Debyser Z; Mortelmans L; Baekelandt V
Mol Ther; 2006 Sep; 14(3):423-31. PubMed ID: 16820324
[TBL] [Abstract][Full Text] [Related]
28. Firefly luciferase enzyme fragment complementation for imaging in cells and living animals.
Paulmurugan R; Gambhir SS
Anal Chem; 2005 Mar; 77(5):1295-302. PubMed ID: 15732910
[TBL] [Abstract][Full Text] [Related]
29. Bioluminescence imaging serves as a dynamic marker for guiding and assessing thermal treatment of cancer in a preclinical model.
Au JT; Gonzalez L; Chen CH; Serganova I; Fong Y
Ann Surg Oncol; 2012 Sep; 19(9):3116-22. PubMed ID: 22466665
[TBL] [Abstract][Full Text] [Related]
30. Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killing.
Brown CE; Wright CL; Naranjo A; Vishwanath RP; Chang WC; Olivares S; Wagner JR; Bruins L; Raubitschek A; Cooper LJ; Jensen MC
J Immunol Methods; 2005 Feb; 297(1-2):39-52. PubMed ID: 15777929
[TBL] [Abstract][Full Text] [Related]
31. Combination of vasostatin and cyclophosphamide in the therapy of murine melanoma tumors.
Jazowiecka-Rakus J; Jarosz M; Kozłowska D; Sochanik A; Szala S
Acta Biochim Pol; 2007; 54(1):125-33. PubMed ID: 17369879
[TBL] [Abstract][Full Text] [Related]
32. A novel bioluminescent tumor model of human renal cancer cell lines: an in vitro and in vivo characterization.
Peter C; Kielstein JT; Clarke-Katzenberg R; Adams MC; Pitsiouni M; Kambham N; Karimi MA; Kengatharan KM; Cooke JP
J Urol; 2007 Jun; 177(6):2342-6. PubMed ID: 17509355
[TBL] [Abstract][Full Text] [Related]
33. Development of a dual-luciferase fusion gene as a sensitive marker for site-directed DNA repair strategies.
Bennett M; Schaack J
J Gene Med; 2003 Aug; 5(8):723-32. PubMed ID: 12898641
[TBL] [Abstract][Full Text] [Related]
34. A new additional reporter enzyme, dinoflagellate luciferase, for monitoring of gene expression in mammalian cells.
Suzuki C; Nakajima Y; Akimoto H; Wu C; Ohmiya Y
Gene; 2005 Jan; 344():61-6. PubMed ID: 15656973
[TBL] [Abstract][Full Text] [Related]
35. Site-directed mutagenesis of firefly luciferase: implication of conserved residue(s) in bioluminescence emission spectra among firefly luciferases.
Tafreshi NKh; Sadeghizadeh M; Emamzadeh R; Ranjbar B; Naderi-Manesh H; Hosseinkhani S
Biochem J; 2008 May; 412(1):27-33. PubMed ID: 18251715
[TBL] [Abstract][Full Text] [Related]
36. Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice.
Sarraf-Yazdi S; Mi J; Dewhirst MW; Clary BM
J Surg Res; 2004 Aug; 120(2):249-55. PubMed ID: 15234220
[TBL] [Abstract][Full Text] [Related]
37. Combination of vasostatin gene therapy with cyclophosphamide inhibits growth of B16(F10) melanoma tumours.
Jazowiecka-Rakus J; Jarosz M; Szala S
Acta Biochim Pol; 2006; 53(1):199-202. PubMed ID: 16388313
[TBL] [Abstract][Full Text] [Related]
38. A novel luciferase fusion protein for highly sensitive optical imaging: from single-cell analysis to in vivo whole-body bioluminescence imaging.
Mezzanotte L; Blankevoort V; Löwik CW; Kaijzel EL
Anal Bioanal Chem; 2014 Sep; 406(23):5727-34. PubMed ID: 24958343
[TBL] [Abstract][Full Text] [Related]
39. Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee.
Bloquel C; Trollet C; Pradines E; Seguin J; Scherman D; Bureau MF
BMC Biotechnol; 2006 Mar; 6():16. PubMed ID: 16524461
[TBL] [Abstract][Full Text] [Related]
40. Proteasome inhibition blocks ligand-induced dynamic processing and internalization of epidermal growth factor receptor via altered receptor ubiquitination and phosphorylation.
Kesarwala AH; Samrakandi MM; Piwnica-Worms D
Cancer Res; 2009 Feb; 69(3):976-83. PubMed ID: 19176375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
